APA

Holmes F. A., Valero V., Walters R. S., Theriault R. L., Booser D. J., Gibbs H., Fraschini G., Buzdar A. U., Willey J., Frye D., Asmar L. & Hortobagyi G. N. (19990811). Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Holmes F A, Valero V, Walters R S, Theriault R L, Booser D J, Gibbs H, Fraschini G, Buzdar A U, Willey J, Frye D, Asmar L and Hortobagyi G N. 19990811. Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Holmes F. A., Valero V., Walters R. S., Theriault R. L., Booser D. J., Gibbs H., Fraschini G., Buzdar A. U., Willey J., Frye D., Asmar L. and Hortobagyi G. N. (19990811). Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Holmes F A, Valero V, Walters R S, Theriault R L, Booser D J, Gibbs H, Fraschini G, Buzdar A U, Willey J, Frye D, Asmar L and Hortobagyi G N. Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results. : Annals of oncology : official journal of the European Society for Medical Oncology. 19990811.